Warfarin-related intracerebral haemorrhage: Better outcomes when reversal includes prothrombin complex concentrates

Internal Medicine Journal

Volumn 43, Issue 3, 2013, Pages 308-316

  Hanger, H C ^a,b   Geddes, J A A ^a,b   Wilkinson, T J ^a,b   Lee, M ^a   Baker, A E ^c  

^a CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Waitemata District Health Board   (New Zealand)

Author keywords

Intracerebral haemorrhage; Oral anticoagulant; Prothrombin complex concentrate; Reversal

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; VITAMIN K GROUP; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE THROMBOSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RETROSPECTIVE STUDY; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM; WARFARIN RELATED INTRACEREBRAL HEMORRHAGE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 84874376350     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12034     Document Type: Article

References (37)

1. Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 2006; 37: 256-262.
2. Neau JP, Couderq C, Ingrand P, Blanchon P, Gill R; VGP Study Group. Intracranial haemorrhage and oral anticoagulant treatment. Cerebrovasc Dis 2001; 11: 195-200.
3. Hanger HC, Fletcher V, Brown AJ, Wilkinson TJ, Frampton CM, Sainsbury R. Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. J Neurol 2008; 255: 347-352.
4. Butler AC, Tait RC. Management of oral anticoagulant induced intracranial haemorrhage. Blood Rev 1998; 12: 35-44.
5. Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, Garcia RC etal. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007; 82: 82-92.
6. Huhtakangas J, Tetri S, Juvela S, Saloheimo P, Bode MK, Hillbom M. Effect of increased warfarin use on warfarin related cerebral hemorrhage: a longitudinal population based study. Stroke 2011; 42: 2431-2435.
7. Masotti L, Napoli MD, Godoy DA, Rafanelli D, Liumbruno G, Koumpouros N etal. The practical management of intracerebral haemorrhage associated with oral anticoagulant therapy. Int J Stroke 2011; 6: 228-240.
8. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-993.
9. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin haematoma expansion and outcome of intracerebral haemorrhage. Neurology 2004; 63: 1059-1064.
10. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA etal. Haematoma growth is a determinant of mortality and poor outcome after intracerebral haemorrhage. Neurology 2006; 66: 1175-1181.
11. Sjoblom L, Hardemark H-G, Lindgren A, Norrving B, Fahlen M, Sameulsson M etal. Management and prognostic features of intracerebral haemorrhage during anticoagulant therapy. Stroke 2001; 32: 2567-2574.
12. Flaherty ML. Anticoagulant associated intracerebral hemorrhage. Semin Neurol 2010; 30: 565-572.
13. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM, Warfarin Reversal Consensus Group. Australasian Society of Thrombosis and Haemostasis guidelines. Med J Aust 2004; 181: 492-497.
14. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC etal. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the factor seven for acute hemorrhage stroke (FAST) trial. Stroke 2010; 41: 48-53.
15. Beard M, Thwaites JH, eds. Bluebook: Management of Common Medical Conditions, 13th edn. Christchurch, New Zealand: Canterbury District Health Board; 2009.
16. Lee M, Geddes J, Hanger HC. Uptake of a prothrombin complex concentrate anticoagulation reversal protocol for warfarin related intracerebral haemorrhage [abstract]. Aust J Ageing 2011; 30(Suppl 1): 16.
17. Sheth KN, Cushing TA, Wendell L, Lev MH, Romero JM, Schwab K etal. Comparison of hematoma shape and volume estimates in warfarin versus non warfarin related intracerebral hemorrhage. Neurocrit Care 2010; 12: 30-34.
18. Mattle HP, Raabe A. CLEAR intraventricular hemorrhage: more than a glimmer of hope. Stroke 2011; 42: 2999-3000.
19. Hemphill JC, Farrant M, Neill TA. Prospective validation of the ICH score for 12 month functional outcome. Neurology 2009; 73: 1088-1094.
20. Hanger HC, Fogarty B, Wilkinson TJ, Sainsbury R. Stroke patients' views on stroke outcomes: death versus disability. Clin Rehabil 2000; 14: 417-424.
21. Freeman WD, Brott TG, Barrett KM, Castillo PR, Deen HG, Czervionke LF etal. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004; 79: 1495-1500.
22. Kuwashiro T, Tasaka M, Itabashi R, Nakagaki H, Miyashita F, Naritomi H etal. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant associated intracerebral haemorrhage. Cerebrovasc Dis 2011; 31: 170-176.
23. Goldstein JN, Thomas SH, Frontiero V, Joseph A, Engel C, Snider R etal. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin related intracerebral haemorrhage. Stroke 2006; 37: 151-155.
24. Zubkov AY, Mandrekar DO, Claasen EM, Manno EFM, Widjicks EFM, Rabenstein AA. Predictors of outcome in warfarin related intracerebral hemorrhage. Arch Neurol 2008; 65: 1320-1325.
25. Imberti D, Barillari G, Biiasioli C, Bianchi M, Contino L, Duce R etal. Emergency reversal of anticoagulation with a three factor prothrombin complex concentrate in patients with intracerebral haemorrhage. Blood Transfus 2011; 9: 148-155.
26. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D etal. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
27. Hanger HC, Wilkinson TJ, Fayez-Iskander N, Sainsbury R. The risk of recurrent stroke after intracerebral haemorrhage. J Neurol Neurosurg Psych 2007; 78: 836-840.
28. Punthakee X, Doobay J, Anand SS. Oral anticoagulant related intracerebral haemorrhage. Thrombosis Res 2003; 108: 31-36.
29. Steiner T, Freiberger A, Griebe M, Husing J, Ivandic B, Kollmar R etal. International normalised ratio normalisation in patients with coumarin related intracranial hemorrhages - the INCH trial: a randomised controlled multicentre trial to compare safety and preliminary efficacy of fresh frozen plasma and prothrombin complex- study design and protocol. Int J Stroke 2011; 6: 271-277.
30. Fredriksson K, Norrving B, Stromblad L-G. Emergency reversal of anticoagulation after intracerebral haemorrhage. Stroke 1992; 23: 972-977.
31. Boulis NM, Bobek MP, Schmaier A, Hoff J. Use of factor IX complex in warfarin related intracranial hemorrhage. Neurosurgery 1999; 45: 1113-1118.
32. Huttner HB, Schellinger PD, Hartmann M, Kohrmann M, Juettler E, Wikner J etal. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy. Stroke 2006; 37: 1465-1470.
33. Cartmill M, Dolan G, Byrne JL, Byrne PO. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000; 14: 458-461.
34. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008; 83: 137-143.
35. Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D, Hylek E etal. Safety of prothrombin complex concentrates for rapid reversal of vitamin K antagonists. Thromb Haemost 2011; 106: 429-438.
36. Tran H, Collecut M, Whitehead S, Salem HH. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation. Intern Med J 2011; 41: 337-343.
37. Prothrombinex™-HT data sheet [cited 2011 Oct 3]. Available from URL: http://www.csl.com.au/s1/cs/auhq/1199978997194/Web_Product_C/1196562733778/ProductDetail.htm.